Investment
Features
FeesSafety
Academy
More
Pluang+

Neogen faces investigation after FDA links its sterile product to horse deaths, stock drops 7.22%.

Market News
13 Oct 2026
GlobeNewsWire
View Source
Bearish
Neogen faces investigation after FDA links its sterile product to horse deaths, stock drops 7.22%.

Pomerantz LLP is investigating Neogen Corporation following an FDA warning about its veterinary product Neogen Vet HYCOAT, which was linked to at least 20 horse deaths due to contamination. This incident is the largest animal death toll tied to a sterile-labeled FDA-regulated veterinary product. Neogen had voluntarily recalled the product in January 2026. The news caused Neogen's stock to fall 7.22% on September 29, 2026. The investigation focuses on potential securities fraud or unlawful business practices by Neogen and its executives.

The story concerns Neogen Corporation and an investigation following an FDA warning. For readers following the health sector, here is Pluang's market snapshot as of Oct 14, 2026 03:41 WIB: out of 128 priced health-sector US stocks, 29 rose and 99 fell. Notable movers include Abeona Therapeutics Inc (ABEO) at USD 4.52 with a 1-day change of -7.76%, Canopy Growth Corp (CGC) at USD 0.76 down 7.53%, and Sana Biotechnology Inc (SANA) at USD 2.44 down 6.87%.

More News

Applied Materials expects strong AI-driven chip equipment demand and aims for high margins by 2030.

Applied Materials expects strong AI-driven chip equipment demand and aims for high margins by 2030.

Applied Materials projects sustained demand for its chipmaking equipment driven by AI infrastructure growth, expecting faster spending on wafer fab equipment through 2030. The company aims to increase its market share by over 2 percentage points from...

Market News
Bullish
2 hours ago
Ollie's Bargain Outlet gains investor confidence with $105 price target and $500M share buyback boost

Ollie's Bargain Outlet gains investor confidence with $105 price target and $500M share buyback boost

Gordon Haskett Capital Corporation set a $105 price target for Ollie's Bargain Outlet, suggesting an 18.1% upside from its current price around $89. The company’s board approved an additional $500 million share repurchase authorization, increasing to...

Market News
Bullish
3 hours ago
FRUIT launches PAVE to integrate human judgment into AI decision-making systems.

FRUIT launches PAVE to integrate human judgment into AI decision-making systems.

FRUIT Holdings, Inc. introduced PAVE, a new protocol designed to allow AI systems to call on human judgment and authority when needed. This approach ensures that human input retains its value, authority, and attribution within AI workflows, addressin...

Others
Bullish
3 hours ago
AngioDynamics Q1 revenue rises 6.9%, but shares drop 21% despite positive results and CEO change.

AngioDynamics Q1 revenue rises 6.9%, but shares drop 21% despite positive results and CEO change.

AngioDynamics reported a 6.9% revenue increase to $80.9 million and a narrowed adjusted loss of 4 cents per share for Q1 fiscal 2027, with strong Med Tech sales growing 13.2%. Despite beating earnings expectations and improved gross margin, the stock...

Company Fundamentals
Bearish
4 hours ago
Nathan's Famous sale to Smithfield Foods under review for fair valuation at $102 per share

Nathan's Famous sale to Smithfield Foods under review for fair valuation at $102 per share

Nathan's Famous, Inc. is proposed to be sold to Smithfield Foods, Inc. with shareholders set to receive $102 in cash per share. The law firm Kahn Swick & Foti, led by former Louisiana Attorney General Charles C. Foti, Jr., is investigating whether th...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App